Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody.

Zika virus (ZIKV), a mosquito-borne flavivirus, is a current global public health concern. The flavivirus envelope (E) glycoprotein is responsible for virus entry and represents a major target of neutralizing antibodies for other flaviviruses. Here, we report the structures of ZIKV E protein at 2.0 Å and in complex with a flavivirus broadly neutralizing murine antibody 2A10G6 at 3.0 Å. ZIKV-E resembles all the known flavivirus E structures but contains a unique, positively charged patch adjacent to the fusion loop region of the juxtaposed monomer, which may influence host attachment. The ZIKV-E-2A10G6 complex structure reveals antibody recognition of a highly conserved fusion loop. 2A10G6 binds to ZIKV-E with high affinity in vitro and neutralizes currently circulating ZIKV strains in vitro and in mice. The E protein fusion loop epitope represents a potential candidate for therapeutic antibodies against ZIKV.

[1]  X. Qiu,et al.  Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection , 2012, PLoS neglected tropical diseases.

[2]  T. Pierson,et al.  The 3.8 Å resolution cryo-EM structure of Zika virus , 2016, Science.

[3]  C. Nelson,et al.  Crystal Structure of the Japanese Encephalitis Virus Envelope Protein , 2011, Journal of Virology.

[4]  Cameron P Simmons,et al.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.

[5]  R. Tesh,et al.  Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms , 2011, Journal of Virology.

[6]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[7]  Y. Modis,et al.  Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.

[8]  P. Desprès,et al.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses , 2015, Nature.

[9]  Oumar Faye,et al.  Molecular Evolution of Zika Virus during Its Emergence in the 20th Century , 2014, PLoS neglected tropical diseases.

[10]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[11]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Wilson,et al.  Epitopes involved in antibody-mediated protection from Ebola virus. , 2000, Science.

[13]  Lei Shi,et al.  Isolation, identification and genomic characterization of the Asian lineage Zika virus imported to China , 2016, Science China Life Sciences.

[14]  D. Montefiori,et al.  A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1* , 2014, The Journal of Biological Chemistry.

[15]  R J Read,et al.  Pushing the boundaries of molecular replacement with maximum likelihood. , 2003, Acta crystallographica. Section D, Biological crystallography.

[16]  C. Mengelle,et al.  Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? , 2016, The Lancet. Infectious diseases.

[17]  C. Rice,et al.  Molecular biology of the flaviviruses. , 1987, Microbiological sciences.

[18]  J. Navaza,et al.  The Fusion Glycoprotein Shell of Semliki Forest Virus An Icosahedral Assembly Primed for Fusogenic Activation at Endosomal pH , 2001, Cell.

[19]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[20]  Chris Doane,et al.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus , 2005, Nature Medicine.

[21]  Dennis C Winkler,et al.  Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres , 2011, EMBO reports.

[22]  James E. Robinson,et al.  Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop , 2012, Journal of Virology.

[23]  P. Wilson,et al.  Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. , 2016, The Journal of clinical investigation.

[24]  G. Chang,et al.  Differentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-Reactivity , 2007, Journal of Clinical Microbiology.

[25]  E. Harris,et al.  Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases , 2013, PLoS neglected tropical diseases.

[26]  G. Nybakken,et al.  Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.

[27]  R M Buckingham,et al.  Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. , 2010, Physical review letters.

[28]  S. Halstead,et al.  High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection , 2013, Journal of Virology.

[29]  G. Dick,et al.  Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  Michael G. Rossmann,et al.  The 3.8 angstrom resolution cryo-EM structure of Zika virus. , 2016 .

[31]  G. Nybakken,et al.  Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus , 2007, Journal of Virology.

[32]  Giovanini Evelim Coelho,et al.  Zika virus in the Americas: Early epidemiological and genetic findings , 2016, Science.

[33]  Soila Sukupolvi-Petty,et al.  The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein , 2013, mBio.

[34]  G. Chang,et al.  Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II , 2008, Journal of Virology.

[35]  Fei Wang,et al.  Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses , 2013, Science.

[36]  T. Pierson,et al.  Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization , 2008, PLoS pathogens.

[37]  Wei Zhang,et al.  Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.

[38]  N. Bohorova,et al.  Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant , 2011, Proceedings of the National Academy of Sciences.

[39]  Hanqin Peng,et al.  Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41 , 2013, Journal of Virology.

[40]  Qinfen Zhang,et al.  CryoEM structure of the mature dengue virus at 3.5-Å resolution , 2012, Nature Structural &Molecular Biology.

[41]  Wei Zhang,et al.  Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation , 2008, Science.

[42]  F. Gao,et al.  Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus , 2010, Protein & Cell.

[43]  Yifan Cheng,et al.  A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies , 2008, Proceedings of the National Academy of Sciences.

[44]  Richard J Kuhn,et al.  Dengue structure differs at the temperatures of its human and mosquito hosts , 2013, Proceedings of the National Academy of Sciences.

[45]  Victor A. Kostyuchenko,et al.  Structure of the thermally stable Zika virus , 2016, Nature.

[46]  G. Gao,et al.  Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus , 2014, Scientific Reports.

[47]  D. Musso,et al.  Emerging arboviruses in the Pacific , 2014, The Lancet.

[48]  Marko Kolenc,et al.  Zika Virus Associated with Microcephaly. , 2016, The New England journal of medicine.

[49]  Cameron P Simmons,et al.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus , 2014, Nature Immunology.

[50]  Jiaqi Wang,et al.  Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C , 2013, Journal of Virology.

[51]  Robert B. Tesh,et al.  Genetic Characterization of Zika Virus Strains: Geographic Expansion of the Asian Lineage , 2012, PLoS neglected tropical diseases.

[52]  Alimuddin Zumla,et al.  Rapid Spread of Zika Virus in The Americas--Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[53]  F. Gao,et al.  Diverse Peptide Presentation of Rhesus Macaque Major Histocompatibility Complex Class I Mamu-A*02 Revealed by Two Peptide Complex Structures and Insights into Immune Escape of Simian Immunodeficiency Virus , 2011, Journal of Virology.

[54]  Ruth R. Montgomery,et al.  Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody1 , 2009, The Journal of Immunology.

[55]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[56]  Qun Li,et al.  Zika Virus in a Traveler Returning to China from Caracas, Venezuela, February 2016 , 2016, Emerging infectious diseases.

[57]  Ya-jun Guo,et al.  A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein , 2011, PloS one.